Evaluation of Cardiac IL-11 and IL-11Rα Expression During T. cruzi Infection

Yarlla Loyane Lira Braga1, José Rodrigues do Carmo Neto1, Pablo Igor Ribeiro Franco1

  • 1Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, GO, 74605-450, Brazil.

Inflammation
|September 12, 2025
PubMed

Insights

Chagas disease cardiomyopathy may involve IL-11Rα, not IL-11, in cardiac fibrosis. Increased IL-11Rα expression correlated with collagen deposition, suggesting a potential therapeutic target.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Parasitology

Background:

  • Chagas disease (CD) affects millions, causing cardiomyopathy in 20-30% of cases.
  • Interleukin-11 (IL-11) is linked to cardiac fibrosis, but its role in CD is unclear.
  • Trypanosoma cruzi strain variability influences disease severity.

Purpose of the Study:

  • Investigate the temporal expression of IL-11 and IL-11 receptor alpha (IL-11Rα) in T. cruzi-infected mouse hearts.
  • Determine the association between IL-11/IL-11Rα and cardiac pathology, including fibrosis and myocarditis.
  • Explore the impact of different T. cruzi strains on immune response and cardiac remodeling.

Main Methods:

  • Infection of C57BL/6 mice with Y or Colombian T. cruzi strains.
  • Monitoring of survival, parasitemia, and organ weights.
  • Cardiac tissue analysis for parasite load, inflammation, collagen deposition, and IL-11Rα expression via histology and ELISA/Cytometric Bead Array.

Main Results:

  • Colombian strain induced more severe myocarditis, parasite load, and collagen deposition than the Y strain.
  • Both strains elicited IFN-γ, TNF-α, and IL-6; Y strain also induced IL-10, IL-4, and IL-17.
  • IL-11 expression remained unchanged, but IL-11Rα progressively increased and correlated with collagen deposition.

Conclusions:

  • IL-11Rα, not IL-11, may drive cardiac remodeling and fibrosis in Chagas disease.
  • T. cruzi strain diversity significantly impacts disease progression and immune profiles.
  • The IL-11/IL-11Rα axis warrants further investigation as a therapeutic target for Chagas cardiomyopathy.